(Q37835774)

24 August 2017

1 reference

title

Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas (English)

1 reference

24 August 2017

3

Andreas von Deimling

0 references

Michael Weller

series ordinal

1

object named as

Michael Weller

1 reference

24 August 2017

2

Wolfgang Wick

1 reference

24 August 2017

3 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

59

1 reference

24 August 2017

1200-1204

1 reference

24 August 2017

8

1 reference

Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review

24 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Metabolism, gliomas, and IDH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Mutant metabolic enzymes are at the origin of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Glutaric aciduria type II [corrected] and brain tumors: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

IDH2 mutations in patients with D-2-hydroxyglutaric aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21130

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/GLIA.21130

1 reference

24 August 2017

1 reference

PubMed ID

21294161